Advanced glycation end products and their receptors in serum of patients with type 2 diabetes
Abstract Glycation is a non-enzymatic process involving the reaction of reducing sugars or reactive oxoaldehyde with proteins, lipids or nucleic acids, which results in the formation of advanced glycation end products (AGEs). The presented work discusses the glycation process in people with advanced...
Enregistré dans:
Auteurs principaux: | Diana Indyk, Agnieszka Bronowicka-Szydełko, Andrzej Gamian, Aleksandra Kuzan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/28fe6f922a48497f9a0698bb45ec8f3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Advanced glycation end products as predictors of renal function in youth with type 1 diabetes
par: Josephine M. Forbes, et autres
Publié: (2021) -
Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
par: Tássia Kirchmann Lazzari, et autres
Publié: (2021) -
The melibiose-derived glycation product mimics a unique epitope present in human and animal tissues
par: Magdalena Staniszewska, et autres
Publié: (2021) -
Advanced Glycation End-Products in Skeletal Muscle Aging
par: Lucas C. Olson, et autres
Publié: (2021) -
Berberine suppresses advanced glycation end products‐associated diabetic retinopathy in hyperglycemic mice
par: Ning Wang, et autres
Publié: (2021)